Qual é o preço para Aroa Biosurgery Limited (ARX)

O preço para Aroa Biosurgery Limited (ARX) é $0.39848591

Qual é a capitalização de mercado para Aroa Biosurgery Limited (ARX)

A capitalização de mercado para Aroa Biosurgery Limited (ARX) é $137.67M

Aroa Biosurgery Limited (ARX) Dividendos

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

Ano	Dividendo (ajustado para desdobramentos)	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Dividendo (ajustado para desdobramentos)

Alterar

Não há dados suficientes para as datas fornecidas.

Ano	Dividendo	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Dividendo

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Número de pagamentos de dividendos	País
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Siemens Healthineers AG SHL.DE	0.00%	DE

Empresa

Número de pagamentos de dividendos

País